• Heparin Sodium for Nanovesicle Uptake Assays

  2026-09-17

  Heparin sodium serves both as a calibrated anticoagulant for coagulation experiments and as a mechanistic competition probe for heparan sulfate proteoglycan-dependent nanovesicle uptake. This workflow connects anti-factor Xa and aPTT readouts with practical cell-uptake assays while separating evidence-backed findings from optimization recommendations.

• Clodronate Liposomes in Macrophage Research

  2026-09-17

  Use Clodronate Liposomes to test whether macrophages are necessary for age-related defects in phagocytosis, tissue inflammation, or repair. This practical guide combines route-aware in vivo macrophage depletion with controls, depletion checks, and assay choices informed by a recent aging study.

• Caspase-4 Colorimetric Assay Kit Workflow

  2026-09-16

  Turn LEVD-dependent caspase-4 activity into a practical 400–405 nm readout for pyroptosis, inflammation, and mechanism-focused cell-death studies. This workflow also shows how to use the assay alongside ER-targeted enzyme-instructed self-assembly research without conflating ER stress with caspase-4 activation.

• Streptozotocin (STZ) in Diabetes Research

  2026-09-16

  Streptozotocin, or STZ, is a DNA-alkylating nitrosourea used to induce pancreatic β-cell injury and experimental diabetes mellitus. Its controlled use can connect β-cell cytotoxicity with downstream studies of hyperglycemia, neuropathy, and neuroinflammation, but STZ is not itself a TBK1 inhibitor or a complete replica of human diabetes.

• MTSEA-biotin and the Next Layer of RNA Biology

  2026-09-15

  Site-specific RNA polymerase II CTD phosphorylation is a regulatory system, not a single transcriptional switch. This thought-leadership perspective explains how MTSEA-biotin can complement FeaSion-style discovery by testing accessibility and conformational hypotheses around candidate CTD regulators, while defining the controls and limitations required for translational confidence.

• Integrating Transcriptomics and Cardiotoxicity Phenotypes

  2026-09-15

  Tsai and colleagues developed an integrated screening framework that combines functional, cytotoxicity, transcriptomic, and exposure-oriented analyses in human iPSC-derived cardiomyocytes. Across 464 chemicals, the study shows that transcriptomic points of departure can complement cardiac phenotypes for hazard prioritization and mechanistic interpretation without replacing conventional risk assessment.

• Doxorubicin Workflows for Cancer and Senescence Models

  2026-09-14

  Doxorubicin, also known as Adriamycin, is a mechanistically defined benchmark for DNA damage, apoptosis, and drug-response studies. This guide shows how to use it in cancer assays and as a carefully controlled stress-model component when evaluating senolytic or senomorphic nanovesicles.

• Cell Lysis Strategy for CAF Chemoresistance

  2026-09-14

  Mechanistic studies of cancer-associated fibroblasts increasingly depend on preserving both protein abundance and protein–protein interactions. This article connects the ANGPTL4–IQGAP1 chemoresistance axis in prostate cancer with practical, translationally oriented protein extraction strategy using Cell lysis buffer for WB and IP.

• Ceftolozane/Tazobactam: Evidence and Research Insights

  2026-09-13

  This review examines how ceftolozane/tazobactam combines a PBP-focused cephalosporin with β-lactamase inhibition to address important resistant Gram-negative pathogens. Its value lies in integrating chemistry, microbiology, pharmacokinetics, pharmacodynamics, clinical trials, and safety evidence while defining where activity should not be overgeneralized.

• Macrophage CCL7 and CRC Immunotherapy Resistance

  2026-09-12

  The reference study identifies CCL7-producing tumor-associated macrophages as a mechanistic driver of colorectal cancer resistance to immune checkpoint blockade. Its integrated genetic, transcriptomic, proteomic, and flow-cytometric approach links macrophage metabolism with reduced CD8+ T-cell infiltration and provides a rationale for combining CCL7-directed strategies with PD-L1 inhibition.

• Morning Training Drives Stronger Endurance Adaptation

  2026-09-11

  A mouse study found that endurance training during the early active phase produced a greater improvement in performance than training during the late active phase, despite lower absolute training volume. The work separates baseline time-of-day performance from training-induced adaptation and links the stronger response to skeletal-muscle remodeling rather than detectable differences in tissue glycogen.

• Isradipine (Dynacirc) for Calcium-Channel Workflows

  2026-09-11

  Isradipine (Dynacirc) provides a practical way to probe L-type calcium-channel contributions in vascular, neuronal, and calcium-imaging assays. This guide connects stock preparation and electrophysiology with neuroprotection, vascular smooth muscle relaxation, troubleshooting, and reference-driven channel selectivity.

• Direct Mouse Genotyping Kit for GEMM Studies

  2026-09-10

  The Direct Mouse Genotyping Kit connects purification-free PCR amplification from mouse tissue with rigorous genetically engineered mouse model design. Learn how K1025 supports allele verification, colony decisions, and high-throughput genotyping in mesothelioma research while preserving essential assay controls.

• CTCF, FLG-AS1, and Macrophage Polarization in PDAC

  2026-09-10

  This study identifies a multilevel regulatory circuit in which CTCF, FLG-AS1, HNRNPU, EP300, IGF2BP2, and CSF1 connect chromatin regulation, RNA modification, alternative splicing, and tumor-associated macrophage polarization in pancreatic ductal adenocarcinoma. The findings provide a mechanistic explanation for how tumor-intrinsic transcriptional regulation can reshape the immune microenvironment and suggest experimental targets for PDAC research.

• Sodium Orthovanadate: From Signal to Translation

  2026-09-09

  Sodium Orthovanadate (Na3VO4) is more than a routine phosphatase inhibitor: it is a reversible intervention for protecting phosphorylation-dependent biology while exposing the interpretive risks of broad enzyme inhibition. This article connects its biochemical role to insulin signaling, adipocyte models, assay design, and translational decision-making.

548 records 4/37 page Previous Next 12345 下5页 Last page